Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

Clinical manifestations and cerebrospinal fluid status in ocular syphilis in HIV-Negative patients

BMC Infectious DiseasesBMC series – open, inclusive and trusted201616:245

https://doi.org/10.1186/s12879-016-1586-z

  • Received: 11 December 2015
  • Accepted: 19 May 2016
  • Published:
Open Peer Review reports

Abstract

Background

Syphilis with ocular involvement has reemerged as a critical health problem. The aim of the present study was to explore the clinical manifestations and cerebrospinal fluid (CSF) status in ocular syphilis in human immunodeficiency virus (HIV)-negative patients.

Methods

The clinical records of patients with ocular syphilis presenting to the Shanghai Xuhui Central Hospital in the period from January 2011 to December 2012 were retrospectively reviewed.

Results

The median age of 25 HIV-negative patients with ocular syphilis was 53 years, 18 patients (72.0 %) were males and 7 (28.0 %) were females. None of them self-identified themselves as men who had sex with men (MSM). The ocular lesions included: uveitis (13 cases), optic neuropathy (6 cases), retinal vasculitis (5 cases), retinal detachment (3 cases), and neuroretinitis (4 cases). Serum toluidine red unheated serum test (TRUST) titer ranged from 1 to 512, with a median of 64. Overall, 18 (72.0 %) of the 25 patients had abnormal CSF results, 15 (60.0 %) CSF samples had elevated white blood cell counts, 13 (52.0 %) had elevated protein levels, and 9 (36.0 %) had reactive CSF Venereal Disease Research Laboratory (VDRL) test, respectively. Mann–Whitney U tests showed higher serum TRUST titer (>32) correlated with the abnormal CSF results.

Conclusions

The demographic characteristics of patients with ocular syphilis in this study were different from previous reports. The study showed a high CSF abnormal rate in HIV-negative patients. The recommendation for CSF examination from all patients with ocular syphilis, including HIV-negative cases, is strongly supported by the present data.

Keywords

  • Cerebrospinal fluid
  • HIV-negative
  • Ocular syphilis

Background

Syphilis is a chronic sexually transmitted disease caused by a spirochete Treponema pallidum subsp. pallidum that can affect most organ systems, including the eyes. Syphilis has been considered as “the great masquerader” and often presents with manifestations similar to various other ocular diseases. It can involve all parts of the eye and may be the only manifestation of syphilis. In the pre-antibiotic era, syphilis was recognized as one of the most common causes of intraocular inflammation. The introduction of penicillin during the 1950s led to a decrease in the incidence of syphilis; hence, vigilance was required in the diagnosis of ocular syphilis [1, 2].

Even with no clinical evidence of central nervous system (CNS) disease, the US Centers for Disease Control and Prevention (CDC) recommended a standard regimen of intravenous penicillin for neurosyphilis at a dose of 18–24 million units daily for 10–14 days [3]. Outside of case reports or small case series, little is known about the concomitant CNS involvement in ocular syphilis. A significantly higher proportion of human immunodeficiency virus (HIV)-positive patients with ocular syphilis compared with HIV-negative cases have been reported in published studies [48]. In a meta-analysis in HIV-positive patients with ocular syphilis, 74 % had elevated cerebrospinal fluid (CSF) white blood cell (WBC) count, 75 % had elevated CSF protein while 57 % had positive CSF Venereal Disease Research Laboratory (VDRL) test [9]. Few data exist about the CSF status in ocular syphilis in HIV-negative individuals. HIV increases the risk for both neurosyphilis and CSF abnormalities [3]; therefore important questions remain about the relationship between ocular syphilis and neurosyphilis. Uncertainties exist in the optimal management of ocular manifestations of syphilis due to a lack of evidence.

The prevalence of syphilis has increased sharply in the last decade in several countries around the world, including China. Since the invention of penicillin, no country has experienced such a dramatic upsurge of reported syphilis cases, as China is presently having [10]. Nationwide surveillance data indicated that the incidence of syphilis in the general population increased from 0.17 cases per 100,000 in 1993 to 20.0 cases per 100,000 in 2010 [11]. Syphilis has now become the most commonly reported communicable disease in Shanghai, the largest city in China, with 76.42 cases per 100,000 reported in 2011 [11, 12]. Syphilis with ocular involvement has reemerged as a critical health problem. A failure to recognize the ocular manifestations of syphilis or delayed diagnosis and treatment can lead to irreversible visual loss. For a better understanding of HIV-negative patients with ocular syphilis, especially CSF status, a case series is presented here.

Methods

Study participants

Located in Shanghai, the Eye & ENT (Eye, Ear, and Throat) Hospital of Fudan University is the biggest Eye and ENT hospital in east China. Patients who visited the hospital with eye, ear or throat-related symptoms suspected of syphilis were suggested to have a blood screening for syphilis, and those screened positive were transferred to Shanghai Xuhui Central Hospital (Shanghai Clinical Center, Chinese Academy of Science) for further treatment. All the patients with ocular syphilis presenting to Shanghai Xuhui Central Hospital were advised to have CSF examination. The clinical records of patients with ocular syphilis in the period from January 2011 to December 2012 were retrospectively reviewed. Individuals were eligible for enrollment in this study if they 1) presented initially with ocular symptoms 2) had serological evidence of syphilis and 3) had completed CSF examination. The collected data included chief complaint, demographic data, cocurrent medical problems, ophthalmologic findings, syphilis serology, HIV serology and CSF examination results. Written informed consents were obtained from all participants for lumbar puncture according to the routine medical procedure.

Laboratory methods

Treponema pallidum particle agglutination (TPPA) tests were conducted using the Serodia-TPPA reagent from Fujirebio Diagnostics Inc (Malven, Pennsylvania, USA). The results were observed according to the manufacturer’s instructions. Serum toluidine red unheated serum test (TRUST) and CSF VDRL tests were performed according to the standard methods. The TRUST reagents were manufactured by Shanghai Rongsheng Biotech, and the VDRL antigen with buffered saline were manufactured by Becton-Dickinson and Company (Diagnostic Systems, MD, USA). All patients underwent HIV screening through a dual enzyme-linked immunosorbent assay.

Statistical methods

Subjects with reactive CSF TPPA were classified as having abnormal CSF if they also met one of the following criteria: reactive CSF VDRL, elevated CSF WBC (>5 cells/mm3) count, or elevated protein level (>45 mg/dL). Qualitative variables were described using frequencies and percentages, while quantitative variables were described using medians and interquartile ranges (IQR). Mann–Whitney U-test was used to compare variables between abnormal and normal CSF subjects. Data were recorded using Microsoft Excel, and analyses were performed using Statistical Package for the Social Sciences (SPSS15.01, SPSS Inc.,, IL, USA).

Ethics statement

The Ethical Committee of the Shanghai Xuhui Central Hospital (Shanghai Clinical Center, Chinese Academy of Science) waived the need for institutional review board approval because of the retrospective nature of this study. The participants were not required to provide written informed consent for their clinical records to be used in this study. Patient information was anonymized and de-identified prior to analysis. The described research adhered to the principles of the Declaration of Helsinki.

Results

During the 2-year period, 25 patients with syphilis were identified who initially presented with ocular symptoms and completed CSF examination. All patients were treated unsuccessfully with nonspecific therapy for ocular symptoms before the correct diagnosis was made. None of them had a previous history of syphilis. The interval between ocular symptom onset and the first visit at the hospital ranged from 2 weeks to 20 years (median 4 months, IQR 13 month). The median age at presentation was 53 years (range 30–77 years). All 25 patients were of Han ethnicity. Eighteen patients (72.0 %) were males, and seven were females (28.0 %). Twenty-four patients (17 males and 7 females) identified themselves as heterosexual; another male refused to provide sexual partner information. One male and three female patients got syphilis infections from their spouses. Of the 25 patients, 3 (12 %) had mucocutaneous manifestation of secondary syphilis, 5 (20 %) had a history of papulomacular rash on the trunk and palms or soles of the feet, 2 (8 %) reported previous genital ulcers, and 15 (60 %) had no systemic signs. Ocular symptoms were bilateral in 16 (64 %) cases. None of the 25 patients tested positive for HIV infection. The ocular lesions included: uveitis (52 %,13 cases), optic neuropathy (24 %, 6 cases), retinal vasculitis (20 %, 5 cases), retinal detachment (12 %, 3 cases), and neuroretinitis (16 %, 4 cases). Six (24 %) patients had multiple ocular lesions. Patients with comorbidities included hypertension (20 %, five cases), diabetes mellitus (24 %, six cases), tuberculosis infection (4 %, one case), hepatitis C (4 %, one case), renal atrophy (4 %, one case), cancer (4 %, one case), and hypercholesterolemia (8 %, two cases). Clinical and CSF features of the 25 patients are presented in Table 1.
Table 1

Demographic, clinical, and laboratory data of patient with ocular syphilis

Case

Age/Sex

Serum TRUST

CSF- VDRL

CSF- WBC cells/mm33

CSF- Protein mg/dL

Ocular findings

1

M

128

N

11

1.44

Neuroretinitis

2

M

16

4

2

0.58

Retinal vasculitis

3

M

64

2

1

0.68

Uveitis, optic neuropathy

4

F

8

N

0

0.23

Uveitis, Neuroretinitis

5

F

16

4

1

0.50

Uveitis

6

F

2

N

0

0.31

Uveitis, retinal vasculitis

7

M

512

4

30

0.4

Uveitis

8

M

128

N

8

0.49

Neuroretinitis

9

M

4

N

3

0.32

Optic neuropathy

10

M

64

N

24

0.46

Retinal detachment

11

M

32

1

15

0.51

Uveitis

12

M

32

N

20

0.54

Uveitis

13

F

2

N

4

0.27

Uveitis

14

M

16

1

23

0.17

Retinal vasculitis

15

F

64

8

64

0.62

Uveitis, optic neuropathy

16

F

128

N

18

0.41

Uveitis, Neuroretinitis

17

M

1

N

4

0.37

Retinal detachment

18

M

4

N

4

0.30

Uveitis

19

M

64

N

12

0.54

Uveitis

20

M

4

N

0

0

Retinal vasculitis

21

M

64

N

41

0.286

Retinal detachment

22

F

64

N

29

0.53

Optic neuropathy

23

M

128

1

10

0.48

Optic neuropathy

24

M

128

N

16

0.3

Uveitis

25

M

64

8

154

0.66

Optic neuropathy

All patients had positive serum TPPA and TRUST results. The range of serum TRUST titer ranged from 1 to 512, with a median of 64. Overall, 18 (72.0 %) of the 25 patients had abnormal CSF results. Of which, 15(60.0 %) CSF samples had elevated WBC counts, 13(52.0 %) had elevated protein level, 9(36.0 %) had reactive CSF VDRL test, respectively. The CSF cell count ranged from 0 to 154, with a median of 11cells/mm3 (normal ≤5 cells/mm3). The CSF protein level ranged from 17 to 144, with a median of 46 mg/dl (normal ≤45 mg/dl). The CSF VDRL titer ranged from 0 to 8.

Mann–Whitney U-test revealed that a higher serum TRUST titer (>32) correlated with the abnormal CSF results (P < 0.05). The other investigated factors including age, gender, and interval between ocular disease onset and the diagnosis were not associated with ocular syphilis (Table 2).
Table 2

Variables associated with abnormal CSF

 

Normal CSF

Abnormal CSF

 

Categorical variables

Freq (%)

Freq (%)

P

Gender

  

0.355

 Male (n = 18)

4 (22.2)

14 (77.8)

 

 Female (n = 7)

3 (42.9)

4 (57.1)

 

Age

  

0.378

  ≤ 50 (n = 10)

4(40.0)

6 (60.0)

 

  > 50 (n = 15)

3 (20.0)

12 (80.0)

 

Basic Serum TRUST

  

<0.001

  ≤ 32(n = 12)

6 (50.0)

6 (50.0)

 

  > 32(n = 13)

1 (7.7)

12 (92.3)

 

Duration

  

0.550

  ≤ 3 month (n = 12)

3 (25.0)

9 (75.0)

 

  > 3 month (n = 13)

4 (30.8)

9 (69.2)

 

Discussion

During the 1960s to 1980s, no new case of ocular syphilis was reported in China. However, dozens of cases with ocular syphilis were reported from a single urban setting in the past two years. This is in accordance with recent syphilis epidemic in China [11, 12].

Most studies on ocular syphilis originated in the Western world, and only a few studies have reported on the features of this disease in Asian patients. In previous reports from the United States, United Kingdom, France and other Western Europe countries, most of the increase in the incidence of syphilis occurred among men, especially young men who had sex with men (MSM) and was associated with the HIV epidemic [1317]. Although most patients here were males, none of them indentified themselves as MSM, except for one male who refused to provide sexual orientation; 12 of the 18 acknowledged a history of unprotected intercourse with female sex workers. Most of the patients in this study were in their fifties to sixties, our recent national survey among male clients with sexually transmitted diseases in China has also shown that elder patients were more likely to have syphilis infection [18]. Older patients of low socio-economic status may be more likely to visit low-fee female sex workers and less likely to use condoms. Furthermore, unlike most reports from Western countries, none of the patients with ocular syphilis were HIV-positive in this study. The result is in agreement with other reports from China;despite a high syphilis rate in some high-risk populations, the HIV infection rate is relatively low [19, 20]. Demographic characteristics of ocular syphilis in the present study were substantially different compared with other reports. The patients in this cohort seemed to be more atypical. If patients are presumed to be in low-risk groups, delays in diagnosis and therapy may be likely.

It is recommended that all patients with ocular complications of syphilis involvement undergo a lumbar puncture. However, most of the previous reports from ophthalmologists were focused on ocular findings. No large studies have been conducted to determine the incidence of concomitant CNS involvement in patients with ocular syphilis. Case series from the pre-HIV era and pooled data in HIV-positive patients suggested that most patients with ocular syphilis had an elevated WBC count or total protein in the CSF, which is consistent with the results of this study [9, 21]. Conflicting data exist about the CSF VDRL results among patients with ocular syphilis. Although up to 54 % HIV-positive patients showed reactive VDRL in pooled analysis, Spoor’s study from the pre-HIV era found that none of the 50 individuals with ocular syphilis had a reactive CSF VDRL [9, 21]. In the present study, all the patients were HIV-negative, and nearly one third had a reactive CSF-VDRL test. It is not surprising that HIV-positive patients had a higher abnormal CSF rate than in HIV-negative patients, since co-infection with HIV could alter the severity of syphilis and increases the likelihood of syphilitic CNS involvement. The discrepancy in CSF characteristics of HIV-negative patients between Spoor’s study and the present results could be explained as follows: Frist, the patient in this study had a higher serum non-treponemal test (100 % had reactive serum TRUST, median titer 64) compared with the Spoor’s report (only 24 % had reactive serum VDRL, titer up to 16) [21]. Second, our previous study showed that the predominant Treponema pallidum genotype in Shanghai was 14d/f (88.8 %), which was suspected to be a high-risk neurosyphilis genotype [22].

The present study found that patients with ocular syphilis having a higher serum TRUST titer (>32) significantly associated with an abnormal CSF. Other investigated factors including age, gender, and interval between ocular disease onset and the diagnosis were not associated with ocular syphilis. These findings are consistent with the previous reports that found a relationship between higher serum non-treponemal test (≥32) and neurosyphilis [22]. This might better explain why the present study had a higher CSF-VDRL compared with the Spoor’s study.

This study had several limitations. First, the clinical data were collected from a single center and the study was retrospective, therefore, both selection and information biases should be acknowledged. Second, the sample size was relatively small, limiting the ability to control confounding variables and perform multiple statistical analyses. Third, syphilis has no pathognomonic ocular presentation. Polymerase chain reaction of aqueous and vitreous humor, can help in making an accurate diagnosis, and hence may be performed in future studies.

Conclusions

The present study showed a high CSF abnormal rate in HIV-negative patients with ocular syphilis. The recommendation for CSF examination from all patients with ocular syphilis including HIV-negative cases is strongly supported by the present data. More research is needed to better understand ocular syphilis among HIV-negative patients.

Abbreviations

CDC, US Centers for Disease Control and Prevention; CNS, central nervous system; CSF, cerebrospinal fluid; ENT, Eye, Ear and Throat; HIV, human immunodeficiency virus; MSM, men who have sex with men; TPPA, Treponema pallidum particle agglutination; TRUST, Toluidine red unheated serum test; VDRL, Venereal Disease Research Laboratory; WBC, white blood cell

Declarations

Acknowledgments

Thank are due to the ophthalmologist from Eye & ENT Hospital of Fudan University who initially diagnosed ocular syphilis and all colleagues who helped to manage these patients.

Funding

This study was supported by Jiangsu University medical fund (JLY20120145), Shanghai Xuhui Central Hospital research project (2015XHYY-07)and Jiangsu Provincial Special Fund for Clinical Sciences and Technology (BL2012003).

Availability of data and materials

All data is contained within the manuscript. Identifying/confidential patient data should not be shared.

Authors’ contributions

DNL, TD, and QQW participated in the study concept and design, and interpreted results. XJW and SNZ supervised the study procedures and provided data. DT was responsible for data analysis and manuscript drafting. All the authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The Ethical Committee of the Shanghai Xuhui Central Hospital waived the need for institutional review board approval because of the retrospective nature of this study.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Dermatology, Shanghai Xuhui Central Hospital, Shanghai, People’s Republic of China
(2)
Department of Neurology, Shanghai Xuhui Central Hospital, Shanghai, People’s Republic of China
(3)
Department of Clinical Management, National Center for STD Control, Nanjing, Jiangsu, People’s Republic of China

References

  1. Tamesis RR, Foster CS. Ocular syphilis. Ophthalmology. 1990;97:1281–7.View ArticlePubMedGoogle Scholar
  2. Gaudio PA. Update on ocular syphilis. Curr Opin Ophthalmol. 2006;17:562–6.View ArticlePubMedGoogle Scholar
  3. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR. 2010;59:28–32.Google Scholar
  4. Nurfahzura MJ, Hanizasurana H, Zunaina E, Adil H. Successful treatment of syphilitic uveitis in HIV-positive patients. Clin Ophthalmol. 2013;7:1651–4.PubMedPubMed CentralGoogle Scholar
  5. Kunkel J, Schürmann D, Pleyer U, Rüther K, Kneifel C, Krause L, Reichert M, Ignatius R, Schneider T. Ocular syphilis–indicator of previously unknown HIV infection. J Infect. 2009;58:32–6.View ArticlePubMedGoogle Scholar
  6. Eandi CM, Neri P, Adelman RA, Yannuzzi LA, Cunningham Jr ET, International Syphilis Study Group. Acute syphilitic posterior placoid chorioretinitis: report of a case series and comprehensive review of the literature. Retina. 2012;32:1915–41.View ArticlePubMedGoogle Scholar
  7. Puech C, Gennai S, Pavese P, Pelloux I, Maurin M, Romanet JP, Chiquet C. Ocular manifestations of syphilis: recent cases over a 2.5-year period. Graefes Arch Clin Exp Ophthalmol. 2010;248:1623–9.View ArticlePubMedGoogle Scholar
  8. Li SY, Birnbaum AD, Tessler HH, Goldstein DA. Posterior syphilitic uveitis: clinical characteristics, co-infection with HIV, response to treatment. Jpn J Ophthalmol. 2011;55:486–94.View ArticlePubMedGoogle Scholar
  9. Tucker JD, Li JZ, Robbins GK, Davis BT, Lobo AM, Kunkel J, Papaliodis GN, Durand ML, Felsenstein D. Ocular syphilis among HIV-infected patients: a systematic analysis of the literature. Sex Transm Infect. 2011;87:4–8.View ArticlePubMedGoogle Scholar
  10. Chen ZQ, Zhang GC, Gong XD, Lin C, Gao X, Liang GJ, Yue XL, Chen XS, Cohen MS. Syphilis in China: results of a national surveillance programme. Lancet. 2007;369:132–8.View ArticlePubMedGoogle Scholar
  11. Chinese Center for Disease Prevention and Control; Center for STI and AIDS. Prevention and Control. 2011 report on syphilis and gonorrhea epidemic analysis in China. Bull STI Prev Control. 2012;26:9–19.Google Scholar
  12. Tucker JD, Chen XS, Peeling RW. Syphilis and social upheaval in China. NEJM. 2010;362:1658–61.View ArticlePubMedGoogle Scholar
  13. Erbelding E, Rompalo A. Changing epidemiology of syphilis and its persistent relationship with HIV. Curr Infect Dis Rep. 2004;6:135–40.View ArticlePubMedGoogle Scholar
  14. Parc CE, Chahed S, Patel SV, Salmon-Ceron D. Manifestations and treatment of ocular syphilis during an epidemic in France. Sex Transm Dis. 2007;34:553–6.View ArticlePubMedGoogle Scholar
  15. Doherty L, Fenton KA, Jones J, Paine TC, Higgins SP, Williams D, Palfreeman A. Syphilis: old problem, new strategy. BMJ. 2002;325:153–6.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Moss AR, Osmond D, Bacchetti P, Chermann JC, Barre-Sinoussi F, Carlson J. Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epidemiol. 1987;125:1035–47.PubMedGoogle Scholar
  17. Mathew RG, Goh BT, Westcott MC. British Ocular Syphilis Study (BOSS): 2-year National Surveillance Study of Intraocular Inflammation Secondary to Ocular Syphilis. Invest Ophthalmol Vis Sci. 2014;12:5394–400.View ArticleGoogle Scholar
  18. Wang QQ, Chen XS, Yin YP, Liang GJ, Jiang N, Dai T, Huan XP, Yang B, Liu Q, Zhou YJ, Wang BX. HIV/STD pattern and its associated risk factors among male STD clinic attendees in China: a foci for HIV intervention. BMC Public Health. 2011;11:955.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Pan X, Zhu Y, Wang Q, Zheng H, Chen X, Su J, Peng Z, Yu R, Wang N. Prevalence of HIV, syphilis, HCV and their high risk behaviors among migrant workers in eastern China. PLoS One. 2013;8(2):e57258.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Chen XS, Wang QQ, Yin YP, Liang GJ, Jiang N, Yang LG, Liu Q, Zhou YJ, Huan XP, Wei WH, Wang B. Prevalence of syphilis infection in different tiers of female sex workers in China: implications for surveillance and interventions. BMC Infect Dis. 2012;12:84.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Spoor TC, Ramocki JM, Nesi FA, Sorscher M. Ocular syphilis 1986. Prevalence of FTA-ABS reactivity and cerebrospinal fluid findings. J Clin Neuroophthalmol. 1987;7(191–195):196–7.Google Scholar
  22. Marra CM, Maxwell CL, Smith SL, Lukehart SA, Rompalo AM, Eaton M, Stoner BP, Augenbraun M, Barker DE, Corbett JJ, Zajackowski M, Raines C, Nerad J, Kee R, Barnett SH. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis. 2004;189:369–76.View ArticlePubMedGoogle Scholar

Copyright

© Dai et al. 2016

Advertisement